Yi Shan

1.7k total citations
53 papers, 708 citations indexed

About

Yi Shan is a scholar working on Oncology, Hematology and Surgery. According to data from OpenAlex, Yi Shan has authored 53 papers receiving a total of 708 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 14 papers in Hematology and 13 papers in Surgery. Recurrent topics in Yi Shan's work include Pancreatic and Hepatic Oncology Research (12 papers), Chronic Myeloid Leukemia Treatments (12 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (6 papers). Yi Shan is often cited by papers focused on Pancreatic and Hepatic Oncology Research (12 papers), Chronic Myeloid Leukemia Treatments (12 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (6 papers). Yi Shan collaborates with scholars based in China, United States and Australia. Yi Shan's co-authors include Shaoguang Li, Yufeng Xu, Juan Ye, Yaoyu Chen, Xiling Lin, Cong Peng, Giulia Cheloni, Yijie Wang, Dongguang Li and Lloyd Hutchinson and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and SHILAP Revista de lepidopterología.

In The Last Decade

Yi Shan

48 papers receiving 696 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yi Shan China 14 231 220 193 112 91 53 708
Irma M. Sáinz United States 16 236 1.0× 188 0.9× 117 0.6× 266 2.4× 115 1.3× 25 741
Laura Cicconi Italy 18 662 2.9× 432 2.0× 118 0.6× 85 0.8× 99 1.1× 32 918
Idoia Martín‐Guerrero Spain 20 456 2.0× 174 0.8× 260 1.3× 103 0.9× 269 3.0× 56 1.0k
Gregory N. Adams United States 10 194 0.8× 126 0.6× 77 0.4× 135 1.2× 55 0.6× 15 550
Chul‐Soo Cho South Korea 12 181 0.8× 154 0.7× 87 0.5× 40 0.4× 39 0.4× 19 602
Stefan Wilop Germany 21 631 2.7× 377 1.7× 237 1.2× 188 1.7× 130 1.4× 48 1.1k
Sandra Cauwenberghs Netherlands 15 390 1.7× 356 1.6× 160 0.8× 53 0.5× 155 1.7× 17 964
Andrew Yen United States 14 365 1.6× 283 1.3× 103 0.5× 179 1.6× 26 0.3× 25 755
Angela Men United States 8 125 0.5× 162 0.7× 206 1.1× 129 1.2× 25 0.3× 12 597
Dolly Aguilera United States 15 296 1.3× 51 0.2× 83 0.4× 293 2.6× 49 0.5× 46 676

Countries citing papers authored by Yi Shan

Since Specialization
Citations

This map shows the geographic impact of Yi Shan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Shan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Shan more than expected).

Fields of papers citing papers by Yi Shan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi Shan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Shan. The network helps show where Yi Shan may publish in the future.

Co-authorship network of co-authors of Yi Shan

This figure shows the co-authorship network connecting the top 25 collaborators of Yi Shan. A scholar is included among the top collaborators of Yi Shan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yi Shan. Yi Shan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Peng, Peng, Yi Shan, Haodong Zhang, et al.. (2025). Huayu Xiaopi Decoction regulates the JNK/c-Jun/Slug pathway to inhibit epithelial-mesenchymal transformation and improve precancerous lesions of gastric cancer. Journal of Ethnopharmacology. 354. 120503–120503.
2.
Shan, Yi, et al.. (2025). Global, regional and national patterns and gender disparity of intraocular foreign bodies from 1990 to 2021. Frontiers in Public Health. 13. 1620358–1620358.
3.
Tang, Chengyuan, et al.. (2023). Nr4a1 promotes renal interstitial fibrosis by regulating the p38 MAPK phosphorylation. Molecular Medicine. 29(1). 63–63. 19 indexed citations
4.
Ju, Wei, Yi Shan, Xiao Zheng, et al.. (2022). Anp32e promotes renal interstitial fibrosis by upregulating the expression of fibrosis-related proteins. International Journal of Biological Sciences. 18(15). 5897–5912. 8 indexed citations
5.
Xu, Yufeng, Yi Shan, Xiling Lin, et al.. (2021). Global patterns in vision loss burden due to vitamin A deficiency from 1990 to 2017. Public Health Nutrition. 24(17). 5786–5794. 30 indexed citations
6.
Xu, Yufeng, Yi Shan, Yin Hu, et al.. (2021). Case Report: An Adult Patient With Deficiency of Adenosine Deaminase 2 Resembled Unilateral Frosted Branch Angiitis. Frontiers in Medicine. 8. 642454–642454. 8 indexed citations
7.
Hu, Yin, Yi Shan, Qiang Du, et al.. (2021). Gender and Socioeconomic Disparities in Global Burden of Epilepsy: An Analysis of Time Trends From 1990 to 2017. Frontiers in Neurology. 12. 643450–643450. 50 indexed citations
8.
Shan, Yi, et al.. (2020). Clinicopathological analysis of 719 pediatric and adolescents’ ocular tumors and tumor-like lesions: a retrospective study from 2000 to 2018 in China. International Journal of Ophthalmology. 13(12). 1961–1967. 7 indexed citations
9.
Zeng, Dong, Xiao Zheng, Qianqian Xu, et al.. (2020). Norcantharidin protects against renal interstitial fibrosis by suppressing TWEAK-mediated Smad3 phosphorylation. Life Sciences. 260. 118488–118488. 8 indexed citations
10.
Tusa, Ignazia, Giulia Cheloni, Antonella Gozzini, et al.. (2018). Targeting the Extracellular Signal-Regulated Kinase 5 Pathway to Suppress Human Chronic Myeloid Leukemia Stem Cells. Stem Cell Reports. 11(4). 929–943. 20 indexed citations
11.
Zhu, Yu, Luo Lu, Chun Qiao, et al.. (2018). Targeting PFKFB3 sensitizes chronic myelogenous leukemia cells to tyrosine kinase inhibitor. Oncogene. 37(21). 2837–2849. 26 indexed citations
12.
Cheloni, Giulia, Michele Tanturli, Ignazia Tusa, et al.. (2017). Targeting chronic myeloid leukemia stem cells with the hypoxia-inducible factor inhibitor acriflavine. Blood. 130(5). 655–665. 69 indexed citations
13.
Chen, Yaoyu, Yi Shan, Min Lü, et al.. (2016). Alox5 Blockade Eradicates JAK2V617F -Induced Polycythemia Vera in Mice. Cancer Research. 77(1). 164–174. 10 indexed citations
14.
Zhou, Jianguo, Qian Zhang, Peng Li, et al.. (2013). Prognostic factors of carcinoma of the ampulla of Vater after surgery. Tumor Biology. 35(2). 1143–1148. 11 indexed citations
15.
Xie, Yibin, et al.. (2013). Risk factors associated with postoperative hospital stay after pancreaticoduodenectomy: a retrospective study. Chinese Medical Journal. 126(19). 3685–3689. 5 indexed citations
16.
Peng, Cong, Yaoyu Chen, Yi Shan, et al.. (2012). LSK Derived LSK– Cells Have a High Apoptotic Rate Related to Survival Regulation of Hematopoietic and Leukemic Stem Cells. PLoS ONE. 7(6). e38614–e38614. 12 indexed citations
17.
Sullivan, Con, Yaoyu Chen, Yi Shan, et al.. (2011). Functional Ramifications for the Loss of P-Selectin Expression on Hematopoietic and Leukemic Stem Cells. PLoS ONE. 6(10). e26246–e26246. 19 indexed citations
18.
Zhao, Ping, Ye‐Xiong Li, Yi Shan, et al.. (2010). [Role of 125I seed implantation in treatment of unresectable pancreatic cancer].. PubMed. 90(2). 92–5. 5 indexed citations
19.
Shan, Yi, Xu Che, Dongbing Zhao, et al.. (2007). [Surgical management of ovarian metastasis from colorectal cancer].. PubMed. 10(2). 146–8. 1 indexed citations
20.
Wang, Li, Xiaoping Miao, Wen‐Hann Tan, et al.. (2005). Genetic Polymorphisms in Methylenetetrahydrofolate Reductase and Thymidylate Synthase and Risk of Pancreatic Cancer. Clinical Gastroenterology and Hepatology. 3(8). 743–751. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026